Details for New Drug Application (NDA): 073449
✉ Email this page to a colleague
The generic ingredient in TRIAMTERENE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Summary for 073449
Tradename: | TRIAMTERENE AND HYDROCHLOROTHIAZIDE |
Applicant: | Watson Labs |
Ingredient: | hydrochlorothiazide; triamterene |
Patents: | 0 |
Pharmacology for NDA: 073449
Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |
Suppliers and Packaging for NDA: 073449
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRIAMTERENE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 073449 | ANDA | Actavis Pharma, Inc. | 0591-0424 | 0591-0424-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-0424-01) |
TRIAMTERENE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 073449 | ANDA | Actavis Pharma, Inc. | 0591-0424 | 0591-0424-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0591-0424-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;37.5MG | ||||
Approval Date: | Sep 23, 1993 | TE: | AB | RLD: | No |
Complete Access Available with Subscription